Corporate

Abbott launches Panbio™M COVID-19 Antigen Self-Test in India

sarkarimirror

Abbott launches Panbio™M COVID-19 Antigen Self-Test in India

The Self-Test features a minimally invasive nasal swab and delivers results in 15 minutes without instrumentation. “Self-testing is a proven tool that provides an added layer of defense along with public health protocols and the vaccine roll out.” said Sanjeev Johar, divisional vice president of Abbott’s rapid diagnostics business in Asia Pacific.